<DOC>
	<DOC>NCT01035346</DOC>
	<brief_summary>This single-dose trial will evaluate the efficacy of a novel ibuprofen formulation compared to placebo in patients with a fever due to an uncomplicated acute infection.</brief_summary>
	<brief_title>Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Subjects diagnosed with a fever secondary to an uncomplicated acute viral or bacterial infection. Oral temperature measurement from 100 to 104 degrees Fahrenheit. Onset of fever 3 days or less. Otherwise good health. Fever secondary to a chronic underlying medical condition or serious infection. Currently taking antibiotics or antivirals. Currently taking any medication which may interfere with the assessment of fever. Pregnancy or breastfeeding. Any serious medical or psychiatric disorder.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Fever</keyword>
	<keyword>antipyretic</keyword>
	<keyword>uncomplicated acute viral infection</keyword>
	<keyword>uncomplicated acute bacterial infections</keyword>
</DOC>